Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer
A Phase III Study of Regional Radiation Therapy in Early Breast Cancer
Sponsor: NCIC Clinical Trials Group
Listed as NCT00005957, this NA trial focuses on Breast Cancer and remains completed. Sponsored by NCIC Clinical Trials Group, it has been updated 11 times since 2000, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2023 — Jul 2024 [monthly]
Completed NA
-
May 2023 — Sep 2023 [monthly]
Completed NA
▶ Show 6 earlier versions
-
Jan 2021 — May 2023 [monthly]
Completed NA
-
May 2020 — Jan 2021 [monthly]
Completed NA
-
Aug 2019 — May 2020 [monthly]
Completed NA
Phase: PHASE3 → NA
-
Jun 2018 — Aug 2019 [monthly]
Completed PHASE3
-
Jul 2017 — Jun 2018 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Jan 2017 — Jul 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
Mar 2000
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- NCIC Clinical Trials Group
- NSABP Foundation Inc
- National Cancer Institute (NCI)
- North Central Cancer Treatment Group
- Radiation Therapy Oncology Group
- SWOG Cancer Research Network
- Trans Tasman Radiation Oncology Group
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Calgary, Canada , Edmonton, Canada , Greater Sudbury, Canada , Halifax, Canada , Hamilton, Canada , Kitchener, Canada , London, Canada , Moncton, Canada , Montreal, Canada , Ottawa, Canada and 13 more locations